Norilsk Nickel plans to invest more than $12bn in production development over the next five years in order to boost production volumes, Mr. Potanin told President Vladimir Putin in a meeting on December 10th.

The company aims to benefit from an expected demand rise on the part of electric vehicle manufacturers.

In July 2018, Petrovax Pharm received Marketing Authorization No. LP-004951 for Grippol® Quadrivalent, a 4-valent inactivated subunit adjuvanted vaccine designed for prevention of influenza. It is the most advanced flu vaccine in the world that employs an antigen sparing technology and has a high preventive activity and safety.